Meilleure Health International Industry Group Limited announced that Mr. Wu Peng has been appointed as an independent non-executive Director of the Company; Mr. Liu Lailin has tendered his resignation as an executive Director of the Company in order to allocate more time to other business engagement and commitment; and Dr. Zeng Wentao has been re-designated from an independent non-executive Director to an executive Director of the Company. Mr. Wu Peng has been appointed a member of the Nomination Committee of the Board; Mr. Liu Lailin has ceased to be a member of the Remuneration Committee and the Strategic Committee of the Board due to his resignation from the position as an executive Director; and Dr. Zeng Wentao has ceased to be a member of the Nomination Committee of the Board and has been appointed as a member of the Remuneration Committee and the Strategic Committee of the Board. The Board announced the re-designation of Mr. Zhou Xuzhou (currently the Chairman of the Board) and the appointment of Dr. Zeng Wentao as Co-Chairmen of the Board, conditional upon certain amendments to the Bye-laws of the Company having been approved by the Shareholders of the Company. Following such re-designation and appointment, Dr. Zeng will be fully involved in the management of the Company and will work closely with Mr. Zhou Xuzhou. Mr. Zhou Xuzhou has confirmed that he will continue to play an active role in the management of the Group and will remain fully committed to the Group. Mr. Wu Peng has been appointed as an independent non-executive Director of the Company with effect from 27 May 2019.